Human Mycobiota and Its Role in Cancer Progression, Diagnostics and Therapeutics: A Link Lesser-Known

References

• Gulmez O, Baris O, Gulmez O, Baris O. Fungal growth and pathology. Fungal Reproduction and Growth [Internet]. 2022 Mar 6. [cited 2023 Feb 20]. Available from: https://www.intechopen.com/chapters/80758.
   Google Scholar
• Murff S. Fungus or cancer: is it or is it not? Arch Biomed Eng Biotechnol. 2019;1(2):6–9.
   Google Scholar
• Kainz K, Bauer MA, Madeo F, Carmona-Gutierrez D. Fungal infections in humans: the silent crisis. Microb Cell. 2020 Jun 6;7(6):143–145. [cited 2023 Feb 20]. Available from: /pmc/articles/PMC7278517/ doi:10.15698/mic2020.06.718.
   PubMed Web of Science ®Google Scholar
• Fungal Disease Frequency - Gaffi | Gaffi - global action for fungal infections [Internet]. [cited 2023 Feb 19]. Available from: https://gaffi.org/why/fungal-disease-frequency/.
   Google Scholar
• Rodrigues ML, Albuquerque PC. Searching for a change: The need for increased support for public health and research on fungal diseases. PLoS Negl Trop Dis. 2018 Jun 1;12(6):e0006479. [cited 2023 Feb 19]. Available from: /pmc/articles/PMC6001980/ doi:10.1371/journal.pntd.0006479.
   PubMed Web of Science ®Google Scholar
• Rodrigues ML, Nosanchuk JD. Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLoS Negl Trop Dis. 2020 Feb 1;14(2):e0007964. [cited 2023 Feb 20]. Available from:/pmc/articles/PMC7032689/ doi:10.1371/journal.pntd.0007964.
   PubMed Web of Science ®Google Scholar
• Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Med Rep. 2011 Jul 1;3(1):14. doi:10.3410/M3-14.
   PubMedGoogle Scholar
• Karavalakis G, Yannaki E, Papadopoulou A. Reinforcing the immunocompromised host defense against fungi: progress beyond the current state of the art. J Fungi. 2021;7(6):451. doi:10.3390/jof7060451.
   Web of Science ®Google Scholar
• Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022 Aug 2;7(8):1127–1140. [cited 2023 Feb 20]. Available from: https://www.nature.com/articles/s41564-022-01172-2
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May 1;8(5):475–481. [cited 2023 Feb 20]. Available from: http://www.thelancet.com/article/S2213260020300795/fulltext doi:10.1016/S2213-2600(20)30079-5.
   PubMed Web of Science ®Google Scholar
• Roy S, Bhowmick P, Mukherjee P, Dey K, Choudhury L. Mucormycosis in COVID-19 patients: a fungal disease decoded. Int J Biol Pharm Allied Sci. 2022;11(11):4979–4995. doi:10.31032/ijbpas/2022/11.11.6533.
   Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020 Jun 16;11:1446. doi:10.3389/fimmu.2020.01446.
   PubMed Web of Science ®Google Scholar
• Romani L. Cell mediated immunity to fungi: a reassessment. Med Mycol. 2008 Sep 1;46(6):515–529. [cited 2023 Feb 19]. Available from: https://academic.oup.com/mmy/article/46/6/515/1019112
   PubMed Web of Science ®Google Scholar
• Guimarães MD, Marchiori E, De Souza Portes Meirelles G, Hochhegger B, Santana PRP, Gross JL, et al. Fungal infection mimicking pulmonary malignancy: Clinical and radiological characteristics. Lung [Internet]. 2013 Dec 17;191(6):655–662. [cited 2023 Feb 20]. Available from: doi:https://doi.org/10.1007/s00408-013-9506-0
   Google Scholar
• Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 2022 Sep 29;185(20):3789–3806.e17. doi:10.1016/j.cell.2022.09.005.
   PubMed Web of Science ®Google Scholar
• Huët MAL, Lee CZ, Rahman S. A review on association of fungi with the development and progression of carcinogenesis in the human body. Curr Res Microb Sci. 2022 Jan 1;3:100090. doi:10.1016/j.crmicr.2021.100090.
   PubMedGoogle Scholar
• Limon JJ, Skalski JH, Underhill DM. Commensal fungi in health and disease. Cell Host Microbe. 2017 Aug 9;22(2):156–165. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/28799901/
   PubMed Web of Science ®Google Scholar
• Kho ZY, Lal SK. The human gut microbiome - a potential controller of wellness and disease. Front Microbiol. 2018 Aug 14;9:1835. doi:10.3389/fmicb.2018.01835.
   PubMed Web of Science ®Google Scholar
• Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019 Oct 10;574(7777):264–267. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/31578522/ doi:10.1038/s41586-019-1608-2.
   PubMed Web of Science ®Google Scholar
• Elaskandrany M, Patel R, Patel M, Miller G, Saxena D, Saxena A. Microbiome-based therapeutics and their physiological effects: fungi, host immune response, and tumorigenesis. Am J Physiol Gastrointest Liver Physiol. 2021 Aug 8;321(2):G213–G222. [cited 2023 Feb 19]. Available from:/pmc/articles/PMC8410104/ doi:10.1152/ajpgi.00025.2021.
   PubMedGoogle Scholar
• Matijašić M, Meštrović T, Paljetak HČ, Perić M, Barešić A, Verbanac D. Gut microbiota beyond bacteria-mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci. 2020;21(8):2668. doi:10.3390/ijms21082668.
   PubMed Web of Science ®Google Scholar
• Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014;14(6):405–416. [cited 2023 Feb 19]. Available from:/pmc/articles/PMC4332855/ doi:10.1038/nri3684.
   PubMed Web of Science ®Google Scholar
• Billoo AG, Memon MA, Khaskheli SA, Murtaza G, Iqbal K, Saeed Shekhani M, et al. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol. 2006 Jul 28;12(28):4557–4560. [cited 2023 Feb 19]. Available from: https://www.wjgnet.com/1007-9327/full/v12/i28/4557.htm doi:10.3748/wjg.v12.i28.4557.
   PubMed Web of Science ®Google Scholar
• Jiang TT, Shao TY, Ang WXG, Kinder JM, Turner LH, Pham G, et al. Commensal fungi recapitulate the protective benefits of intestinal bacteria. Cell Host Microbe. 2017 Dec 13;22(6):809–816.e4. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/29174402/ doi:10.1016/j.chom.2017.10.013.
   PubMed Web of Science ®Google Scholar
• Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, et al. Fungal microbiota dysbiosis in IBD. Gut [Internet]. 2017 Jun 1;66(6):1039–1048. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/26843508/
   Google Scholar
• van Tilburg Bernardes E, Pettersen VK, Gutierrez MW, Laforest-Lapointe I, Jendzjowsky NG, Cavin JB, et al. Intestinal fungi are causally implicated in microbiome assembly and immune development in mice. Nat Commun. 2020;11(1):2577. [Internet]. [cited 2023 Feb 20]. Available from: https://www.nature.com/articles/s41467-020-16431-1
   PubMed Web of Science ®Google Scholar
• Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005 Jan;73(1):30–38. [cited 2023 Feb 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/15618138/ doi:10.1128/IAI.73.1.30-38.2005.
   PubMed Web of Science ®Google Scholar
• Arvelo F, Sojo F, Cotte C. Tumour progression and metastasis. Ecancermedicalscience. 2016 Jan 29; 10;10. Available from: /pmc/articles/PMC4754119/ doi:10.3332/ecancer.2016.617.
   Google Scholar
• Loeb LA. Mutator phenotype. Encyclopedia of Cancer [Internet]. 2011. [cited 2023 Feb 20];2416–2419. Available from: doi:10.1007/978-3-642-16483-5_3913.
   Google Scholar
• Hegde PS, Chen DS. Top 10 challenges in cancer immunotherapy. Immunity. 2020 Jan 14;52(1):17–35. doi:10.1016/j.immuni.2019.12.011.
   PubMed Web of Science ®Google Scholar
• Altamas A, Anam A, Manoj Kumar K. Gut microbiota: role and association with tumorigenesis in different malignancies. Mol Biol Rep. 2022;49(8):8087–8107.
   PubMed Web of Science ®Google Scholar
• Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: Friend or foe? Gut. 2020;69(10):1867–1876. doi:10.1136/gutjnl-2020-321153.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761–773. [cited 2023 Feb 19]. Available from:/pmc/articles/PMC5381164/ doi:10.7150/jca.17648.
   PubMed Web of Science ®Google Scholar
• Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020 579:7800 [Internet]. 2020 Mar 11;579(7800):567–574. [cited 2023 Feb 20]. Available from: https://www.nature.com/articles/s41586-020-2095-1
   Google Scholar
• Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019 Sep 15;79(18):4557–4566. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/31350295/
   PubMed Web of Science ®Google Scholar
• Cohen BL, Torres J, Colombel JF. Immunosuppression in inflammatory bowel disease: how much is too much? Curr Opin Gastroenterol. 2012 Jul;28(4):341–348. [cited 2023 Feb 20]. Available from:/pmc/articles/PMC6681654/ doi:10.1097/MOG.0b013e328354567f.
   PubMed Web of Science ®Google Scholar
• Rempe S, Sachdev MS, Bhakta R, Pineda-Roman M, Vaz A, Carlson RW. Coccidioides immitis fungemia: clinical features and survival in 33 adult patients. Heart Lung. 2007 Jan;36(1):64–71. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/17234479/ doi:10.1016/j.hrtlng.2006.10.001.
   PubMed Web of Science ®Google Scholar
• Dupont B. Hepatosplenic candidiasis: a new immune reconstitution inflammatory syndrome? J Mycol Med. 2007 Sep 1;17(3):155–156. doi:10.1016/j.mycmed.2007.07.002.
   Web of Science ®Google Scholar
• Assari T. Chronic granulomatous disease; fundamental stages in our understanding of CGD. Med Immunol [Internet]. 2006 Sep 21;5:1–8. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/16989665/
   Google Scholar
• Wagg C, Schlaeppi K, Banerjee S, Kuramae EE, van der Heijden MGA. Fungal-bacterial diversity and microbiome complexity predict ecosystem functioning. Nat Commun. 2019 Dec 1;10(1):4841. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/31649246/
   PubMedGoogle Scholar
• Noncommunicable Disease Surveillance. Monitoring and reporting [Internet]. [cited 2023 Feb 20. Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/global-adult-tobacco-survey.
   Google Scholar
• Chung LM, Liang JA, Lin CL, Sun LM, Kao CH. Cancer risk in patients with candidiasis: a nationwide population-based cohort study. Oncotarget [Internet]. 2017;8(38):63562–63573. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/28969011/ doi:10.18632/oncotarget.18855.
   PubMedGoogle Scholar
• Nieminen MT, Salaspuro M. Local acetaldehyde—an essential role in alcohol-related upper gastrointestinal tract carcinogenesis. Cancers (Basel). 2018 Jan 1;10(1):11. [cited 2023 Feb 20]. Available from:/pmc/articles/PMC5789361/ doi:10.3390/cancers10010011.
   PubMed Web of Science ®Google Scholar
• Shukla K, Vun I, Lov I, Laparidis G, McCamley C, Ariyawardana A. Role of Candida infection in the malignant transformation of oral leukoplakia: A systematic review of observational studies. Transl Res Oral Oncol. 2019 Apr;4:2057178X1982822. [Internet]. 23 [cited 2023 Feb 20]. Available from: doi:10.1177/2057178X19828229.
   Google Scholar
• Hirani-Hojatti S, Milligan JR, Kovnat A, Brown K, Archer MC. Activation of the C-ha-ras-1 proto-oncogene by methylation in vitro with α-acetoxy-N-nitrosodimethylamine. Mol Carcinog. 1989;2(2):101–106. doi:10.1002/mc.2940020209.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May 1;71(3):209–249. [cited 2023 Feb 20]. Available from: doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Zhu F, Willette-Brown J, Song NY, Lomada D, Song Y, Xue L, et al. Autoreactive T cells and chronic fungal infection drive esophageal carcinogenesis. Cell Host Microbe. 2017 Apr 4;21(4):478–493.e7. [cited 2023 Feb 20]. Available from:/pmc/articles/PMC5868740/ doi:10.1016/j.chom.2017.03.006.
   PubMed Web of Science ®Google Scholar
• Koo S, Kejariwal D, Al-Shehri T, Dhar A, Lilic D. Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation. United European Gastroenterol J. 2017 Aug 1;5(5):625–631. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/28815025/ doi:10.1177/2050640616684404.
   PubMed Web of Science ®Google Scholar
• Hsia CC, Sun TT, Wang YY, Anderson LM, Armstrong D, Good RA. Enhancement of formation of the esophageal carcinogen benzylmethylnitrosamine from its precursors by Candida albicans. Proc Natl Acad Sci U S A. 1981;78(3):1878–1881. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/7015348/ doi:10.1073/pnas.78.3.1878.
   PubMed Web of Science ®Google Scholar
• Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 2022 Feb 14;40(2):153–167.e11. doi:10.1016/j.ccell.2022.01.003.
   PubMed Web of Science ®Google Scholar
• Weinberg EO, Ferran B, Tsukahara Y, Hatch MMS, Han J, Murdoch CE, et al. IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages. PLoS One. 2019 Jan 1;14(1):e0210827. [cited 2023 Feb 20]. Available from: https://doi.org/10.1371/journal.pone.0210827
   PubMed Web of Science ®Google Scholar
• Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol. 2016 Sep 8;70(1):395–411. doi:10.1146/annurev-micro-102215-095513.
   PubMedGoogle Scholar
• Dai Z, Zhang J, Wu Q, Chen J, Liu J, Wang L, et al. The role of microbiota in the development of colorectal cancer. Int J Cancer. 2019 Oct 15;145(8):2032–2041. doi:10.1002/ijc.32017.
   PubMed Web of Science ®Google Scholar
• Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, et al. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22(2):501–518. doi:10.3748/wjg.v22.i2.501.
   PubMed Web of Science ®Google Scholar
• Kaźmierczak-Siedlecka K, Daca A, Fic M, van de Wetering T, Folwarski M, Makarewicz W. Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes. 2020 Nov 1;11(6):1518–1530. doi:10.1080/19490976.2020.1764309.
   PubMed Web of Science ®Google Scholar
• Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2019 Apr;68(4):654–662. doi:10.1136/gutjnl-2018-317178.
   PubMed Web of Science ®Google Scholar
• Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012 Jan;25(1):106–141. doi:10.1128/CMR.00021-11.
   PubMed Web of Science ®Google Scholar
• Jawhara S, Habib K, Maggiotto F, Pignede G, Vandekerckove P, Maes E, et al. Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions. PLoS One. 2012 Jul 27;7(7):e40648. doi:10.1371/journal.pone.0040648.
   PubMed Web of Science ®Google Scholar
• Fakruddin M, Hossain MN, Ahmed MM. Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic. BMC Complement Altern Med. 2017 Jan 21;17(1):64. [cited 2023 Feb 20]. Available from: doi:https://doi.org/10.1186/s12906-017-1591-9
   PubMedGoogle Scholar
• Luan C, Xie L, Yang X, Miao H, Lv N, Zhang R, et al. Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep. 2015 Jan 23;5(1):7980. doi:10.1038/srep07980.
   PubMedGoogle Scholar
• Gamal A, Elshaer M, Alabdely M, Kadry A, McCormick TS, Ghannoum M. The mycobiome: cancer pathogenesis, diagnosis, and therapy. Cancers (Basel). 2022 Jun 10;14(12):2875. doi:10.3390/cancers14122875.
   PubMed Web of Science ®Google Scholar
• Gao R, Kong C, Li H, Huang L, Qu X, Qin N, et al. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer. Eur J Clin Microbiol Infect Dis. 2017 Dec 18;36(12):2457–2468. doi:10.1007/s10096-017-3085-6.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Wang H, Retuerto M, Zhang H, Burkey B, Ghannoum MA, et al. Bacteriome and mycobiome associations in oral tongue cancer. Oncotarget. 2017 Nov 14;8(57):97273–97289. doi:10.18632/oncotarget.21921.
   PubMedGoogle Scholar
• Shay E, Sangwan N, Padmanabhan R, Lundy S, Burkey B, Eng C. Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma. Oncotarget. 2020 Jun 23;11(25):2375–2386. doi:10.18632/oncotarget.27629.
   PubMedGoogle Scholar
• Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Alwine JC, et al. The ovarian cancer oncobiome. Oncotarget. 2017 May 30;8(22):36225–36245. doi:10.18632/oncotarget.16717.
   PubMedGoogle Scholar
• Banerjee S, Wei Z, Tian T, Bose D, Shih NNC, Feldman MD, et al. Prognostic correlations with the microbiome of breast cancer subtypes. Cell Death Dis. 2021 Sep 4;12(9):831. doi:10.1038/s41419-021-04092-x.
   PubMed Web of Science ®Google Scholar
• Shiao SL, Kershaw KM, Limon JJ, You S, Yoon J, Ko EY, et al. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell [Cell]. 2021 Sep 13;39(9):1202–1213.e6. [cited 2023 Feb 20]. Available from: https://pubmed.ncbi.nlm.nih.gov/34329585/ doi:10.1016/j.ccell.2021.07.002.
   PubMed Web of Science ®Google Scholar
• Yang X, Guo Y, Chen C, Shao B, Zhao L, Zhou Q, et al. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. Immunology [Internet]. 2021 Nov 1;164(3):476–493. [cited 2023 Feb 20]. Available from:/pmc/articles/PMC8517597/ doi:10.1111/imm.13397.
   PubMed Web of Science ®Google Scholar
• Zhang M, Kim JA, Huang AYC. Optimizing tumor microenvironment for cancer immunotherapy: β-Glucan-based nanoparticles. Front Immunol. 2018 Feb 26;9(FEB):341. doi:10.3389/fimmu.2018.00341.
   PubMedGoogle Scholar
• Miao L, Wang YY, Zhu L, Wu ZJ, Zhou RM. Endophytic fungi from four plant species: their isolation and antitumor activity. 1992.
   Google Scholar
• He Q, Zeng Q, Shao Y, Zhou H, Li T, Song F, et al. Anti-cervical cancer activity of secondary metabolites of endophytic fungi from Ginkgo biloba. Cancer Biomark. 2020 Jul 3;28(3):371–379. doi:10.3233/CBM-190462.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Adachi Y, Ishii T, Tamura H, Aketagawa J, Tanaka S, et al. Blocking effect of anti-Dectin-1 antibodies on the anti-tumor activity of 1,3-.BETA.-glucan and the binding of dectin-1 to 1,3-.BETA.-glucan. Biol Pharm Bull. 2007;30(8):1384–1389. doi:10.1248/bpb.30.1384.
   PubMed Web of Science ®Google Scholar